Resultados de procura - Courèche Kaderbhaï

  • Mostrando 1 - 5 Resultados de 5
Limitar resultados
  1. 1
    The Role of Molecular Profiling to Predict the Response to Immune Checkpoint Inhibitors in Lung Cancer

    The Role of Molecular Profiling to Predict the Response to Immune Checkpoint Inhibitors in Lung Cancer por Courèche Kaderbhaï, Zoé Tharin, François Ghiringhelli

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies

    Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies por Nicolas Roussot, Courèche Kaderbhaï, François Ghiringhelli

    Publicado 2025
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Antibiotic Use Does Not Appear to Influence Response to Nivolumab

    Antibiotic Use Does Not Appear to Influence Response to Nivolumab por Courèche Kaderbhaï, Corentin Richard, Jean David Fumet, Anne Aarnink, Pascal Foucher, Bruno Coudert, Laure Favier, Aurélie Lagrange, Emeric Limagne, Romain Boidot, François Ghiringhelli

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma

    Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma por Aurélie Bertaut, Caroline Truntzer, Rachid Madkouri, Courèche Kaderbhaï, Valentin Dérangère, Julie Vincent, Bruno Chauffert, Marie Hélène Aubriot-Lorton, Wahlid Farah, Klaus Luc Mourier, Romain Boidot, François Ghiringhelli

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer

    Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer por Loïck Galland, Nicolas Roussot, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhaï, Silvia Ilie, Audrey Hennequin, Manon Réda, Juliette Albuisson, Laurent Arnould, Romain Boidot, Caroline Truntzer, François Ghiringhelli, Sylvain Ladoire

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: